HER2 FISH pharmDx regulatory update

Dako received CE Mark approval in the EU for its HER2 FISH pharmDx to select patients with HER2 positive stomach cancer who may benefit from treatment with Herceptin trastuzumab from Roche (SIX:ROG;...